Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

PAI-1 Level Differences in Malignant Plural Effusion, Parapneumonic Pleuritis, and Cardiac Hydrothorax.

Zentina D, Stukena I, Krams A, Lejnieks A.

Medicina (Kaunas). 2019 Sep 4;55(9). pii: E567. doi: 10.3390/medicina55090567.

2.

Determinants of CAT (COPD Assessment Test) scores in a population of patients with COPD in central and Eastern Europe: The POPE study.

Miravitlles M, Koblizek V, Esquinas C, Milenkovic B, Barczyk A, Tkacova R, Somfay A, Zykov K, Tudoric N, Kostov K, Zbozinkova Z, Svoboda M, Sorli J, Krams A, Valipour A.

Respir Med. 2019 Apr;150:141-148. doi: 10.1016/j.rmed.2019.03.007. Epub 2019 Mar 21.

PMID:
30961941
3.

The European Alpha-1 Research Collaboration (EARCO): a new ERS Clinical Research Collaboration to promote research in alpha-1 antitrypsin deficiency.

Miravitlles M, Chorostowska-Wynimko J, Ferrarotti I, McElvaney NG, O'Hara K, Stolk J, Stockley RA, Turner A, Wilkens M, Greulich T; EARCO Clinical Research Collaboration; Members of the EARCO Clinical Research Collaboration.

Eur Respir J. 2019 Feb 14;53(2). pii: 1900138. doi: 10.1183/13993003.00138-2019. Print 2019 Feb. No abstract available.

PMID:
30765486
4.

Inhaled therapies in patients with moderate COPD in clinical practice: current thinking.

Ariel A, Altraja A, Belevskiy A, Boros PW, Danila E, Fležar M, Koblizek V, Fridlender ZG, Kostov K, Krams A, Milenkovic B, Somfay A, Tkacova R, Tudoric N, Ulmeanu R, Valipour A.

Int J Chron Obstruct Pulmon Dis. 2017 Dec 21;13:45-56. doi: 10.2147/COPD.S145573. eCollection 2018. Review.

5.

Phenotypes of COPD patients with a smoking history in Central and Eastern Europe: the POPE Study.

Koblizek V, Milenkovic B, Barczyk A, Tkacova R, Somfay A, Zykov K, Tudoric N, Kostov K, Zbozinkova Z, Svancara J, Sorli J, Krams A, Miravitlles M, Valipour A.

Eur Respir J. 2017 May 11;49(5). pii: 1601446. doi: 10.1183/13993003.01446-2016. Print 2017 May.

6.

GOLD 2017 on the way to a phenotypic approach? Analysis from the Phenotypes of COPD in Central and Eastern Europe (POPE) Cohort.

Tudoric N, Koblizek V, Miravitlles M, Valipour A, Milenkovic B, Barczyk A, Somfay A, Zykov K, Kostov K, Zbozinkova Z, Svoboda M, Sorli J, Krams A, Tkacova R.

Eur Respir J. 2017 Apr 26;49(4). pii: 1602518. doi: 10.1183/13993003.02518-2016. Print 2017 Apr. No abstract available.

7.

Genotype and allele frequencies of isoniazid-metabolizing enzymes NAT2 and GSTM1 in Latvian tuberculosis patients.

Igumnova V, Capligina V, Krams A, Cirule A, Elferts D, Pole I, Jansone I, Bandere D, Ranka R.

J Infect Chemother. 2016 Jul;22(7):472-7. doi: 10.1016/j.jiac.2016.04.003. Epub 2016 May 25.

PMID:
27236516
8.

Tiotropium versus salmeterol for the prevention of exacerbations of COPD.

Vogelmeier C, Hederer B, Glaab T, Schmidt H, Rutten-van Mölken MP, Beeh KM, Rabe KF, Fabbri LM; POET-COPD Investigators.

N Engl J Med. 2011 Mar 24;364(12):1093-1103. doi: 10.1056/NEJMoa1008378.

9.

Precancerous gastric conditions in high Helicobacter pylori prevalence areas: comparison between Eastern European (Lithuanian, Latvian) and Asian (Taiwanese) patients.

Jonaitis L, Ivanauskas A, Janciauskas D, Funka K, Sudraba A, Tolmanis I, Krams A, Stirna D, Vanags A, Kupcinskas L, Leja M, Lin JT.

Medicina (Kaunas). 2007;43(8):623-9.

Supplemental Content

Loading ...
Support Center